Clinical trial
Subscalp Placement Of The LINQII Device: A First-in-human Device Feasibility Study
NCT07752251 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Subscalp Placement Of The LINQII Device: A First-in-human Device Feasibility Study
- Lead sponsor
- Mayo Clinic
- Phase
- Not applicable
- Overall status
- Enrolling by invitation
- Start date
- November 30, 2026
- Completion date
- November 30, 2027
- Enrollment
- 10 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cranial neurosurgery